Breaking News

Metrics Appoints BD Manager

June 23, 2014

Savage lead business development opportunities for Southeast region

Natasha Savage has been appointed to lead business development and account management activities for Metrics Inc.’s Southeastern clients, and will work to identify and expand new business opportunities.  
 
Ms. Savage has 15 years of experience in the pharma industry, including working as an analytical chemist for Metrics. Most recently, she served as director of business development for Intertek’s Pharmaceutical Services division, and held in business development roles at Piramal and Celsis.
 
“Natasha made a significant impact and impression during her time at Metrics, so we are excited to have her back,” said Tom Salus, director of sales. “With her analytical chemistry background and knowledge of pharmaceutical development, Natasha thoroughly understands what support our clients need and how Metrics can best help them. We welcome her return to our team.”
  • API Sourcing Trends

    Kristin Brooks, Contract Pharma||April 11, 2016
    Drug product complexities, quality and regulatory hurdles drive market shift

  • Setting a Precedent for Biosimilars in the U.S.

    Setting a Precedent for Biosimilars in the U.S.

    Kristin Brooks, Contract Pharma||May 19, 2015
    Niall Dinwoodie of Charles River discusses several key industry issues on biosimilars and addresses some of the development and regulatory hurdles that remain

  • API Sourcing Trends

    API Sourcing Trends

    Kristin Brooks, Contract Pharma||March 19, 2015
    Ed Price of PCI Synthesis addresses trends, regulatory and supply chain hurdles, and quality concerns

  • Limiting APIs in Manufacturing Effluent

    Limiting APIs in Manufacturing Effluent

    Joan Tell, Robert Drinane, Bruce Naumann, Jessica Vestel, and Gregory Gagliano, Merck & Co., Inc.||June 2, 2016
    An approach for setting limits on pharmaceuticals discharged in manufacturing effluent

  • Biopharma CMO Market Trends

    Biopharma CMO Market Trends

    Tim Wright, Editor||June 2, 2016
    Continued strong growth in biopharma industry is being driven by biosimilars

  • Continuous Pharmaceutical Processes and Their Demands

    Continuous Pharmaceutical Processes and Their Demands

    Girish Malhotra, EPCOT International||April 5, 2016
    A look at the unique characteristics of continuous processes in pharmaceutical manufacturing.